Your session is about to expire
← Back to Search
Optical Imaging for Gum Disease
N/A
Recruiting
Led By Seok-Hyun Yun, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to use a new technique to measure the stiffness of human body parts, in people, without surgery. #medtech
Who is the study for?
This trial is for people aged 18-75 with healthy eyes. It's designed to test a new imaging technique on various tissues, including gums, skin, and corneas.
What is being tested?
The study is testing OCT Vibrography (OCT elastography), an optical imaging method that measures how stiff or elastic human tissues are without needing surgery.
What are the potential side effects?
Since the trial involves non-invasive optical imaging, there are minimal expected side effects. However, participants may experience discomfort from bright lights or minor inconvenience during the procedure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of subjects to successfully complete OCT Vibrography without serious unanticipated adverse events related to application of the device.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: Keratoconus corneaExperimental Treatment1 Intervention
Optical imaging of the cornea in mild and moderate keratoconus
Group II: Healthy skinExperimental Treatment1 Intervention
Optical imaging of the skin in healthy subjects
Group III: Healthy gingivaExperimental Treatment1 Intervention
Optical imaging of the gingiva in healthy subjects
Group IV: Healthy corneaExperimental Treatment1 Intervention
Optical imaging of the cornea in healthy subjects
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
3,026 Previous Clinical Trials
13,413,730 Total Patients Enrolled
Massachusetts Eye and Ear InfirmaryOTHER
111 Previous Clinical Trials
12,769 Total Patients Enrolled
Seok-Hyun Yun, PhDPrincipal InvestigatorMassachusetts General Hospital
2 Previous Clinical Trials
77 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 75 years old with healthy eyes.I have had eye diseases or surgeries in the past.I have diabetes or a family history of glaucoma.I have open sores or an infection in my gums.I am between 18 and 75 years old with healthy skin.I am between 18 and 75 years old with healthy gums.I am 18-40 years old with mild or moderate keratoconus.I have open cuts, skin infections, or a contagious skin condition.I have had repeated episodes of corneal erosion.
Research Study Groups:
This trial has the following groups:- Group 1: Healthy cornea
- Group 2: Healthy skin
- Group 3: Healthy gingiva
- Group 4: Keratoconus cornea
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.